nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ABCB1—Dactinomycin—sarcoma	0.103	0.289	CbGbCtD
Estriol—ABCB1—Mitoxantrone—sarcoma	0.0926	0.259	CbGbCtD
Estriol—ABCB1—Vincristine—sarcoma	0.0637	0.178	CbGbCtD
Estriol—ABCB1—Etoposide—sarcoma	0.0584	0.163	CbGbCtD
Estriol—ABCB1—Doxorubicin—sarcoma	0.0398	0.111	CbGbCtD
Estriol—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.0198	0.109	CbGpPWpGaD
Estriol—SHBG—hindlimb—sarcoma	0.0179	0.128	CbGeAlD
Estriol—ESR1—periosteum—sarcoma	0.0177	0.127	CbGeAlD
Estriol—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.0126	0.0693	CbGpPWpGaD
Estriol—ESR2—Ovarian Infertility Genes—GJA4—sarcoma	0.0113	0.0621	CbGpPWpGaD
Estriol—ESR2—mammary gland—sarcoma	0.00769	0.0551	CbGeAlD
Estriol—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.00648	0.0356	CbGpPWpGaD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.0056	0.0308	CbGpPWpGaD
Estriol—ESR1—mammary gland—sarcoma	0.00526	0.0378	CbGeAlD
Estriol—ESR2—hematopoietic system—sarcoma	0.00468	0.0336	CbGeAlD
Estriol—SHBG—hematopoietic system—sarcoma	0.00455	0.0327	CbGeAlD
Estriol—ESR2—connective tissue—sarcoma	0.00451	0.0324	CbGeAlD
Estriol—SHBG—connective tissue—sarcoma	0.00438	0.0314	CbGeAlD
Estriol—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00418	0.023	CbGpPWpGaD
Estriol—ESR2—smooth muscle tissue—sarcoma	0.00412	0.0296	CbGeAlD
Estriol—ESR1—LKB1 signaling events—EZR—sarcoma	0.00401	0.022	CbGpPWpGaD
Estriol—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.00381	0.021	CbGpPWpGaD
Estriol—SLCO1A2—hematopoietic system—sarcoma	0.00378	0.0271	CbGeAlD
Estriol—ESR1—myometrium—sarcoma	0.00374	0.0268	CbGeAlD
Estriol—ESR1—embryo—sarcoma	0.00359	0.0258	CbGeAlD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.00358	0.0197	CbGpPWpGaD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.00355	0.0195	CbGpPWpGaD
Estriol—ESR2—uterus—sarcoma	0.00354	0.0254	CbGeAlD
Estriol—SHBG—uterus—sarcoma	0.00344	0.0247	CbGeAlD
Estriol—ESR2—lymphoid tissue—sarcoma	0.0033	0.0237	CbGeAlD
Estriol—ESR1—hematopoietic system—sarcoma	0.00321	0.023	CbGeAlD
Estriol—ESR1—connective tissue—sarcoma	0.00309	0.0222	CbGeAlD
Estriol—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.00294	0.0162	CbGpPWpGaD
Estriol—SHBG—bone marrow—sarcoma	0.00292	0.0209	CbGeAlD
Estriol—ESR1—smooth muscle tissue—sarcoma	0.00283	0.0203	CbGeAlD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00282	0.0155	CbGpPWpGaD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00259	0.0142	CbGpPWpGaD
Estriol—ESR2—testis—sarcoma	0.00257	0.0184	CbGeAlD
Estriol—SHBG—testis—sarcoma	0.00249	0.0179	CbGeAlD
Estriol—ESR2—liver—sarcoma	0.00243	0.0174	CbGeAlD
Estriol—ESR1—uterus—sarcoma	0.00242	0.0174	CbGeAlD
Estriol—SHBG—liver—sarcoma	0.00236	0.0169	CbGeAlD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.00228	0.0125	CbGpPWpGaD
Estriol—ESR1—lymphoid tissue—sarcoma	0.00226	0.0162	CbGeAlD
Estriol—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.00223	0.0123	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—WT1—sarcoma	0.0021	0.0116	CbGpPWpGaD
Estriol—SLCO1A2—testis—sarcoma	0.00207	0.0149	CbGeAlD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00197	0.0108	CbGpPWpGaD
Estriol—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.00196	0.0108	CbGpPWpGaD
Estriol—SLCO1A2—liver—sarcoma	0.00196	0.0141	CbGeAlD
Estriol—ESR2—lymph node—sarcoma	0.00186	0.0133	CbGeAlD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00183	0.0101	CbGpPWpGaD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.00179	0.00985	CbGpPWpGaD
Estriol—ESR1—testis—sarcoma	0.00176	0.0126	CbGeAlD
Estriol—Acute coronary syndrome—Vincristine—sarcoma	0.00167	0.00519	CcSEcCtD
Estriol—ESR1—liver—sarcoma	0.00166	0.0119	CbGeAlD
Estriol—Myocardial infarction—Vincristine—sarcoma	0.00166	0.00516	CcSEcCtD
Estriol—Acute coronary syndrome—Mitoxantrone—sarcoma	0.00162	0.00506	CcSEcCtD
Estriol—Myocardial infarction—Mitoxantrone—sarcoma	0.00161	0.00503	CcSEcCtD
Estriol—Erythema multiforme—Dactinomycin—sarcoma	0.00161	0.005	CcSEcCtD
Estriol—Eye disorder—Thiotepa—sarcoma	0.0016	0.00498	CcSEcCtD
Estriol—Cardiac disorder—Thiotepa—sarcoma	0.00159	0.00495	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.00158	0.0087	CbGpPWpGaD
Estriol—Breast pain—Epirubicin—sarcoma	0.00157	0.0049	CcSEcCtD
Estriol—Angiopathy—Thiotepa—sarcoma	0.00155	0.00484	CcSEcCtD
Estriol—Immune system disorder—Thiotepa—sarcoma	0.00155	0.00482	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00152	0.00837	CbGpPWpGaD
Estriol—Bone disorder—Epirubicin—sarcoma	0.00152	0.00473	CcSEcCtD
Estriol—Alopecia—Thiotepa—sarcoma	0.00151	0.00471	CcSEcCtD
Estriol—Alopecia—Dactinomycin—sarcoma	0.0015	0.00468	CcSEcCtD
Estriol—Mental disorder—Thiotepa—sarcoma	0.0015	0.00467	CcSEcCtD
Estriol—Connective tissue disorder—Vincristine—sarcoma	0.00149	0.00465	CcSEcCtD
Estriol—Malnutrition—Thiotepa—sarcoma	0.00149	0.00464	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.00148	0.00815	CbGpPWpGaD
Estriol—ABCB1—myometrium—sarcoma	0.00148	0.0106	CbGeAlD
Estriol—Tension—Thiotepa—sarcoma	0.00146	0.00455	CcSEcCtD
Estriol—Breast pain—Doxorubicin—sarcoma	0.00146	0.00453	CcSEcCtD
Estriol—Nervousness—Thiotepa—sarcoma	0.00145	0.00451	CcSEcCtD
Estriol—Back pain—Thiotepa—sarcoma	0.00144	0.00449	CcSEcCtD
Estriol—ABCB1—embryo—sarcoma	0.00142	0.0102	CbGeAlD
Estriol—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.00141	0.00776	CbGpPWpGaD
Estriol—Cardiac disorder—Vincristine—sarcoma	0.00141	0.00439	CcSEcCtD
Estriol—Bone disorder—Doxorubicin—sarcoma	0.00141	0.00438	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.0014	0.00771	CbGpPWpGaD
Estriol—Angiopathy—Vincristine—sarcoma	0.00138	0.00429	CcSEcCtD
Estriol—Vaginal inflammation—Epirubicin—sarcoma	0.00137	0.00428	CcSEcCtD
Estriol—Pulmonary embolism—Epirubicin—sarcoma	0.00137	0.00428	CcSEcCtD
Estriol—Infestation NOS—Etoposide—sarcoma	0.00137	0.00427	CcSEcCtD
Estriol—Infestation—Etoposide—sarcoma	0.00137	0.00427	CcSEcCtD
Estriol—Acute coronary syndrome—Etoposide—sarcoma	0.00135	0.00421	CcSEcCtD
Estriol—Myocardial infarction—Etoposide—sarcoma	0.00134	0.00418	CcSEcCtD
Estriol—Alopecia—Vincristine—sarcoma	0.00134	0.00418	CcSEcCtD
Estriol—ABCB1—seminal vesicle—sarcoma	0.00133	0.00956	CbGeAlD
Estriol—Mental disorder—Vincristine—sarcoma	0.00133	0.00414	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.00131	0.0072	CbGpPWpGaD
Estriol—Alopecia—Mitoxantrone—sarcoma	0.00131	0.00407	CcSEcCtD
Estriol—Fluid retention—Epirubicin—sarcoma	0.0013	0.00406	CcSEcCtD
Estriol—Vaginal infection—Epirubicin—sarcoma	0.0013	0.00404	CcSEcCtD
Estriol—Hepatobiliary disease—Etoposide—sarcoma	0.0013	0.00403	CcSEcCtD
Estriol—Hypertension—Thiotepa—sarcoma	0.00129	0.00401	CcSEcCtD
Estriol—Back pain—Vincristine—sarcoma	0.00128	0.00398	CcSEcCtD
Estriol—ESR1—lymph node—sarcoma	0.00127	0.00914	CbGeAlD
Estriol—Pulmonary embolism—Doxorubicin—sarcoma	0.00127	0.00396	CcSEcCtD
Estriol—Vaginal inflammation—Doxorubicin—sarcoma	0.00127	0.00396	CcSEcCtD
Estriol—ABCB1—hematopoietic system—sarcoma	0.00127	0.00909	CbGeAlD
Estriol—Anxiety—Thiotepa—sarcoma	0.00126	0.00394	CcSEcCtD
Estriol—Cramps of lower extremities—Epirubicin—sarcoma	0.00126	0.00393	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00126	0.00392	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.00125	0.00688	CbGpPWpGaD
Estriol—Back pain—Mitoxantrone—sarcoma	0.00124	0.00388	CcSEcCtD
Estriol—Neoplasm—Epirubicin—sarcoma	0.00124	0.00387	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.00124	0.0068	CbGpPWpGaD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.00123	0.00679	CbGpPWpGaD
Estriol—Infection—Thiotepa—sarcoma	0.00121	0.00376	CcSEcCtD
Estriol—Oedema—Dactinomycin—sarcoma	0.00121	0.00376	CcSEcCtD
Estriol—Fluid retention—Doxorubicin—sarcoma	0.00121	0.00376	CcSEcCtD
Estriol—Infection—Dactinomycin—sarcoma	0.0012	0.00373	CcSEcCtD
Estriol—Vaginal infection—Doxorubicin—sarcoma	0.0012	0.00373	CcSEcCtD
Estriol—Abnormal vision—Epirubicin—sarcoma	0.0012	0.00373	CcSEcCtD
Estriol—Nervous system disorder—Thiotepa—sarcoma	0.00119	0.00371	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—CREB1—sarcoma	0.00119	0.00654	CbGpPWpGaD
Estriol—Skin disorder—Thiotepa—sarcoma	0.00118	0.00368	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.00118	0.0065	CbGpPWpGaD
Estriol—Cramps of lower extremities—Doxorubicin—sarcoma	0.00117	0.00363	CcSEcCtD
Estriol—Erythema multiforme—Etoposide—sarcoma	0.00116	0.00362	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—sarcoma	0.00115	0.00358	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.00115	0.00633	CbGpPWpGaD
Estriol—Eye disorder—Etoposide—sarcoma	0.00115	0.00358	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—sarcoma	0.00115	0.00358	CcSEcCtD
Estriol—Cardiac disorder—Etoposide—sarcoma	0.00114	0.00355	CcSEcCtD
Estriol—Hypertension—Vincristine—sarcoma	0.00114	0.00355	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.00113	0.00621	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.00112	0.00616	CbGpPWpGaD
Estriol—Angiopathy—Etoposide—sarcoma	0.00112	0.00347	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—sarcoma	0.00111	0.00347	CcSEcCtD
Estriol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.00111	0.00612	CbGpPWpGaD
Estriol—Hypertension—Mitoxantrone—sarcoma	0.00111	0.00346	CcSEcCtD
Estriol—Immune system disorder—Etoposide—sarcoma	0.00111	0.00346	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—sarcoma	0.00111	0.00345	CcSEcCtD
Estriol—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.0011	0.00605	CbGpPWpGaD
Estriol—Cardiac failure congestive—Epirubicin—sarcoma	0.0011	0.00342	CcSEcCtD
Estriol—Anxiety—Mitoxantrone—sarcoma	0.00109	0.0034	CcSEcCtD
Estriol—Alopecia—Etoposide—sarcoma	0.00109	0.00338	CcSEcCtD
Estriol—Oedema—Vincristine—sarcoma	0.00108	0.00336	CcSEcCtD
Estriol—Anaphylactic shock—Vincristine—sarcoma	0.00108	0.00336	CcSEcCtD
Estriol—Infection—Vincristine—sarcoma	0.00107	0.00334	CcSEcCtD
Estriol—Dyspepsia—Thiotepa—sarcoma	0.00107	0.00333	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—sarcoma	0.00106	0.00332	CcSEcCtD
Estriol—Nervous system disorder—Vincristine—sarcoma	0.00106	0.00329	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.00105	0.00578	CbGpPWpGaD
Estriol—Anaphylactic shock—Mitoxantrone—sarcoma	0.00105	0.00327	CcSEcCtD
Estriol—Oedema—Mitoxantrone—sarcoma	0.00105	0.00327	CcSEcCtD
Estriol—Gastrointestinal disorder—Thiotepa—sarcoma	0.00105	0.00327	CcSEcCtD
Estriol—Infection—Mitoxantrone—sarcoma	0.00104	0.00325	CcSEcCtD
Estriol—Pain—Thiotepa—sarcoma	0.00104	0.00324	CcSEcCtD
Estriol—Back pain—Etoposide—sarcoma	0.00104	0.00322	CcSEcCtD
Estriol—Shock—Mitoxantrone—sarcoma	0.00103	0.00322	CcSEcCtD
Estriol—Pain—Dactinomycin—sarcoma	0.00103	0.00321	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—sarcoma	0.00103	0.00321	CcSEcCtD
Estriol—Muscle spasms—Etoposide—sarcoma	0.00103	0.00321	CcSEcCtD
Estriol—Skin disorder—Mitoxantrone—sarcoma	0.00102	0.00318	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—sarcoma	0.00102	0.00317	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—sarcoma	0.00102	0.00317	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.00101	0.00555	CbGpPWpGaD
Estriol—Gastrointestinal pain—Thiotepa—sarcoma	0.000994	0.0031	CcSEcCtD
Estriol—ESR2—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000992	0.00546	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000988	0.00544	CbGpPWpGaD
Estriol—Gastrointestinal pain—Dactinomycin—sarcoma	0.000987	0.00307	CcSEcCtD
Estriol—Migraine—Epirubicin—sarcoma	0.000981	0.00305	CcSEcCtD
Estriol—Insomnia—Vincristine—sarcoma	0.000975	0.00304	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000969	0.00533	CbGpPWpGaD
Estriol—Urticaria—Thiotepa—sarcoma	0.000966	0.00301	CcSEcCtD
Estriol—Abdominal pain—Thiotepa—sarcoma	0.000961	0.00299	CcSEcCtD
Estriol—ABCB1—uterus—sarcoma	0.000957	0.00687	CbGeAlD
Estriol—Abdominal pain—Dactinomycin—sarcoma	0.000954	0.00297	CcSEcCtD
Estriol—Cerebrovascular accident—Doxorubicin—sarcoma	0.000941	0.00293	CcSEcCtD
Estriol—Gastrointestinal disorder—Vincristine—sarcoma	0.000931	0.0029	CcSEcCtD
Estriol—Dyspepsia—Mitoxantrone—sarcoma	0.000924	0.00288	CcSEcCtD
Estriol—Hypertension—Etoposide—sarcoma	0.000924	0.00288	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.000923	0.00508	CbGpPWpGaD
Estriol—Pain—Vincristine—sarcoma	0.000922	0.00287	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000921	0.00507	CbGpPWpGaD
Estriol—Migraine—Doxorubicin—sarcoma	0.000907	0.00283	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000905	0.00282	CcSEcCtD
Estriol—Breast disorder—Epirubicin—sarcoma	0.0009	0.0028	CcSEcCtD
Estriol—Pain—Mitoxantrone—sarcoma	0.000898	0.0028	CcSEcCtD
Estriol—Hypersensitivity—Thiotepa—sarcoma	0.000896	0.00279	CcSEcCtD
Estriol—ABCB1—lymphoid tissue—sarcoma	0.000892	0.0064	CbGeAlD
Estriol—Hypersensitivity—Dactinomycin—sarcoma	0.000889	0.00277	CcSEcCtD
Estriol—Gastrointestinal pain—Vincristine—sarcoma	0.000882	0.00275	CcSEcCtD
Estriol—Anaphylactic shock—Etoposide—sarcoma	0.000874	0.00272	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.000873	0.00481	CbGpPWpGaD
Estriol—Infection—Etoposide—sarcoma	0.000868	0.0027	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—sarcoma	0.000867	0.0027	CcSEcCtD
Estriol—Asthma—Epirubicin—sarcoma	0.000861	0.00268	CcSEcCtD
Estriol—Pruritus—Thiotepa—sarcoma	0.00086	0.00268	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000859	0.00473	CbGpPWpGaD
Estriol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000859	0.00267	CcSEcCtD
Estriol—Abdominal pain—Vincristine—sarcoma	0.000853	0.00266	CcSEcCtD
Estriol—Skin disorder—Etoposide—sarcoma	0.000849	0.00264	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000841	0.00463	CbGpPWpGaD
Estriol—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.00084	0.00462	CbGpPWpGaD
Estriol—Urticaria—Mitoxantrone—sarcoma	0.000834	0.0026	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000834	0.00459	CbGpPWpGaD
Estriol—Breast disorder—Doxorubicin—sarcoma	0.000833	0.00259	CcSEcCtD
Estriol—Diarrhoea—Thiotepa—sarcoma	0.000832	0.00259	CcSEcCtD
Estriol—Abdominal pain—Mitoxantrone—sarcoma	0.00083	0.00259	CcSEcCtD
Estriol—Diarrhoea—Dactinomycin—sarcoma	0.000826	0.00257	CcSEcCtD
Estriol—ABCB1—bone marrow—sarcoma	0.000812	0.00583	CbGeAlD
Estriol—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.000805	0.00443	CbGpPWpGaD
Estriol—Dizziness—Thiotepa—sarcoma	0.000804	0.0025	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000804	0.00442	CbGpPWpGaD
Estriol—Abdominal distension—Doxorubicin—sarcoma	0.000802	0.0025	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000797	0.00438	CbGpPWpGaD
Estriol—Asthma—Doxorubicin—sarcoma	0.000797	0.00248	CcSEcCtD
Estriol—Hypersensitivity—Vincristine—sarcoma	0.000795	0.00247	CcSEcCtD
Estriol—Weight increased—Epirubicin—sarcoma	0.000784	0.00244	CcSEcCtD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.00078	0.00429	CbGpPWpGaD
Estriol—Weight decreased—Epirubicin—sarcoma	0.000779	0.00243	CcSEcCtD
Estriol—Hypersensitivity—Mitoxantrone—sarcoma	0.000774	0.00241	CcSEcCtD
Estriol—Vomiting—Thiotepa—sarcoma	0.000773	0.00241	CcSEcCtD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000768	0.00423	CbGpPWpGaD
Estriol—Infestation—Epirubicin—sarcoma	0.000768	0.00239	CcSEcCtD
Estriol—Infestation NOS—Epirubicin—sarcoma	0.000768	0.00239	CcSEcCtD
Estriol—Vomiting—Dactinomycin—sarcoma	0.000767	0.00239	CcSEcCtD
Estriol—Rash—Thiotepa—sarcoma	0.000767	0.00239	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000767	0.00422	CbGpPWpGaD
Estriol—Dermatitis—Thiotepa—sarcoma	0.000766	0.00239	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000762	0.00419	CbGpPWpGaD
Estriol—Headache—Thiotepa—sarcoma	0.000762	0.00237	CcSEcCtD
Estriol—Rash—Dactinomycin—sarcoma	0.000761	0.00237	CcSEcCtD
Estriol—ESR2—Gene Expression—FUS—sarcoma	0.000761	0.00419	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Etoposide—sarcoma	0.000754	0.00235	CcSEcCtD
Estriol—Pain—Etoposide—sarcoma	0.000747	0.00233	CcSEcCtD
Estriol—Diarrhoea—Vincristine—sarcoma	0.000738	0.0023	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000727	0.004	CbGpPWpGaD
Estriol—Hepatobiliary disease—Epirubicin—sarcoma	0.000726	0.00226	CcSEcCtD
Estriol—Weight increased—Doxorubicin—sarcoma	0.000725	0.00226	CcSEcCtD
Estriol—Nausea—Thiotepa—sarcoma	0.000722	0.00225	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—sarcoma	0.000721	0.00225	CcSEcCtD
Estriol—Diarrhoea—Mitoxantrone—sarcoma	0.000719	0.00224	CcSEcCtD
Estriol—Nausea—Dactinomycin—sarcoma	0.000717	0.00223	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000716	0.00394	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000715	0.00394	CbGpPWpGaD
Estriol—Gastrointestinal pain—Etoposide—sarcoma	0.000714	0.00222	CcSEcCtD
Estriol—Dizziness—Vincristine—sarcoma	0.000713	0.00222	CcSEcCtD
Estriol—Infestation NOS—Doxorubicin—sarcoma	0.00071	0.00221	CcSEcCtD
Estriol—Infestation—Doxorubicin—sarcoma	0.00071	0.00221	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000708	0.0039	CbGpPWpGaD
Estriol—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.0007	0.00385	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000699	0.00385	CbGpPWpGaD
Estriol—ABCB1—testis—sarcoma	0.000694	0.00498	CbGeAlD
Estriol—Urticaria—Etoposide—sarcoma	0.000694	0.00216	CcSEcCtD
Estriol—Abdominal pain—Etoposide—sarcoma	0.000691	0.00215	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—MYC—sarcoma	0.000687	0.00378	CbGpPWpGaD
Estriol—Vomiting—Vincristine—sarcoma	0.000686	0.00214	CcSEcCtD
Estriol—Rash—Vincristine—sarcoma	0.00068	0.00212	CcSEcCtD
Estriol—Dermatitis—Vincristine—sarcoma	0.000679	0.00212	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—sarcoma	0.000679	0.00211	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—sarcoma	0.000677	0.00211	CcSEcCtD
Estriol—Headache—Vincristine—sarcoma	0.000676	0.0021	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—sarcoma	0.000672	0.00209	CcSEcCtD
Estriol—Vomiting—Mitoxantrone—sarcoma	0.000668	0.00208	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000666	0.00366	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000665	0.00366	CbGpPWpGaD
Estriol—Visual impairment—Epirubicin—sarcoma	0.000664	0.00207	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000664	0.00365	CbGpPWpGaD
Estriol—Rash—Mitoxantrone—sarcoma	0.000662	0.00206	CcSEcCtD
Estriol—Dermatitis—Mitoxantrone—sarcoma	0.000662	0.00206	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.00066	0.00363	CbGpPWpGaD
Estriol—Headache—Mitoxantrone—sarcoma	0.000658	0.00205	CcSEcCtD
Estriol—ABCB1—liver—sarcoma	0.000656	0.00471	CbGeAlD
Estriol—Erythema multiforme—Epirubicin—sarcoma	0.000652	0.00203	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000651	0.00358	CbGpPWpGaD
Estriol—Eye disorder—Epirubicin—sarcoma	0.000644	0.00201	CcSEcCtD
Estriol—Hypersensitivity—Etoposide—sarcoma	0.000644	0.002	CcSEcCtD
Estriol—Nausea—Vincristine—sarcoma	0.000641	0.002	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—sarcoma	0.00064	0.00199	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000637	0.00351	CbGpPWpGaD
Estriol—Oedema peripheral—Doxorubicin—sarcoma	0.000628	0.00196	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—sarcoma	0.000627	0.00195	CcSEcCtD
Estriol—Angiopathy—Epirubicin—sarcoma	0.000625	0.00195	CcSEcCtD
Estriol—Nausea—Mitoxantrone—sarcoma	0.000624	0.00194	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000623	0.00343	CbGpPWpGaD
Estriol—Immune system disorder—Epirubicin—sarcoma	0.000623	0.00194	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000622	0.00342	CbGpPWpGaD
Estriol—Pruritus—Etoposide—sarcoma	0.000618	0.00192	CcSEcCtD
Estriol—Visual impairment—Doxorubicin—sarcoma	0.000615	0.00191	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000609	0.00335	CbGpPWpGaD
Estriol—Alopecia—Epirubicin—sarcoma	0.000609	0.0019	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000605	0.00333	CbGpPWpGaD
Estriol—Mental disorder—Epirubicin—sarcoma	0.000604	0.00188	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—sarcoma	0.000603	0.00188	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000602	0.00331	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.0006	0.0033	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.0006	0.0033	CbGpPWpGaD
Estriol—Malnutrition—Epirubicin—sarcoma	0.0006	0.00187	CcSEcCtD
Estriol—Diarrhoea—Etoposide—sarcoma	0.000598	0.00186	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000597	0.00329	CbGpPWpGaD
Estriol—Eye disorder—Doxorubicin—sarcoma	0.000596	0.00186	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000596	0.00328	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000595	0.00328	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000595	0.00328	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000594	0.00327	CbGpPWpGaD
Estriol—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000593	0.00326	CbGpPWpGaD
Estriol—Cardiac disorder—Doxorubicin—sarcoma	0.000592	0.00184	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000592	0.00326	CbGpPWpGaD
Estriol—Flatulence—Epirubicin—sarcoma	0.000591	0.00184	CcSEcCtD
Estriol—Tension—Epirubicin—sarcoma	0.000589	0.00183	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000587	0.00323	CbGpPWpGaD
Estriol—Nervousness—Epirubicin—sarcoma	0.000583	0.00182	CcSEcCtD
Estriol—Back pain—Epirubicin—sarcoma	0.00058	0.00181	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.00058	0.00319	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000579	0.00319	CbGpPWpGaD
Estriol—Angiopathy—Doxorubicin—sarcoma	0.000579	0.0018	CcSEcCtD
Estriol—Dizziness—Etoposide—sarcoma	0.000578	0.0018	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—sarcoma	0.000577	0.0018	CcSEcCtD
Estriol—Immune system disorder—Doxorubicin—sarcoma	0.000576	0.00179	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000575	0.00316	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—TP53—sarcoma	0.000565	0.00311	CbGpPWpGaD
Estriol—Alopecia—Doxorubicin—sarcoma	0.000564	0.00176	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000561	0.00309	CbGpPWpGaD
Estriol—Mental disorder—Doxorubicin—sarcoma	0.000559	0.00174	CcSEcCtD
Estriol—Vomiting—Etoposide—sarcoma	0.000555	0.00173	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—sarcoma	0.000555	0.00173	CcSEcCtD
Estriol—Rash—Etoposide—sarcoma	0.000551	0.00172	CcSEcCtD
Estriol—Dermatitis—Etoposide—sarcoma	0.00055	0.00171	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000549	0.00302	CbGpPWpGaD
Estriol—Headache—Etoposide—sarcoma	0.000547	0.0017	CcSEcCtD
Estriol—Flatulence—Doxorubicin—sarcoma	0.000547	0.0017	CcSEcCtD
Estriol—Tension—Doxorubicin—sarcoma	0.000545	0.0017	CcSEcCtD
Estriol—Nervousness—Doxorubicin—sarcoma	0.000539	0.00168	CcSEcCtD
Estriol—Back pain—Doxorubicin—sarcoma	0.000537	0.00167	CcSEcCtD
Estriol—Muscle spasms—Doxorubicin—sarcoma	0.000534	0.00166	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000528	0.00291	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000524	0.00288	CbGpPWpGaD
Estriol—Nausea—Etoposide—sarcoma	0.000519	0.00162	CcSEcCtD
Estriol—Hypertension—Epirubicin—sarcoma	0.000518	0.00161	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000516	0.00284	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000515	0.00284	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000514	0.00283	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000512	0.00281	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000511	0.00281	CbGpPWpGaD
Estriol—Anxiety—Epirubicin—sarcoma	0.000509	0.00159	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000507	0.00158	CcSEcCtD
Estriol—ABCB1—lymph node—sarcoma	0.000503	0.00361	CbGeAlD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.0005	0.00275	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000492	0.0027	CbGpPWpGaD
Estriol—Oedema—Epirubicin—sarcoma	0.00049	0.00153	CcSEcCtD
Estriol—Anaphylactic shock—Epirubicin—sarcoma	0.00049	0.00153	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000489	0.00269	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000487	0.00268	CbGpPWpGaD
Estriol—Infection—Epirubicin—sarcoma	0.000486	0.00152	CcSEcCtD
Estriol—Shock—Epirubicin—sarcoma	0.000482	0.0015	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—sarcoma	0.00048	0.0015	CcSEcCtD
Estriol—Hypertension—Doxorubicin—sarcoma	0.000479	0.00149	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000476	0.00262	CbGpPWpGaD
Estriol—Skin disorder—Epirubicin—sarcoma	0.000476	0.00148	CcSEcCtD
Estriol—Anxiety—Doxorubicin—sarcoma	0.000471	0.00147	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000469	0.00146	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000466	0.00256	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000465	0.00256	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000461	0.00254	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000455	0.0025	CbGpPWpGaD
Estriol—Oedema—Doxorubicin—sarcoma	0.000453	0.00141	CcSEcCtD
Estriol—Anaphylactic shock—Doxorubicin—sarcoma	0.000453	0.00141	CcSEcCtD
Estriol—Infection—Doxorubicin—sarcoma	0.00045	0.0014	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000449	0.00247	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000447	0.00246	CbGpPWpGaD
Estriol—Shock—Doxorubicin—sarcoma	0.000446	0.00139	CcSEcCtD
Estriol—Nervous system disorder—Doxorubicin—sarcoma	0.000444	0.00138	CcSEcCtD
Estriol—Insomnia—Epirubicin—sarcoma	0.000443	0.00138	CcSEcCtD
Estriol—Skin disorder—Doxorubicin—sarcoma	0.00044	0.00137	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000435	0.0024	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000433	0.00238	CbGpPWpGaD
Estriol—Dyspepsia—Epirubicin—sarcoma	0.000431	0.00134	CcSEcCtD
Estriol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000423	0.00132	CcSEcCtD
Estriol—Pain—Epirubicin—sarcoma	0.000419	0.0013	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000414	0.00228	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000414	0.00228	CbGpPWpGaD
Estriol—Insomnia—Doxorubicin—sarcoma	0.00041	0.00128	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000404	0.00223	CbGpPWpGaD
Estriol—Gastrointestinal pain—Epirubicin—sarcoma	0.0004	0.00125	CcSEcCtD
Estriol—Dyspepsia—Doxorubicin—sarcoma	0.000399	0.00124	CcSEcCtD
Estriol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000391	0.00122	CcSEcCtD
Estriol—Urticaria—Epirubicin—sarcoma	0.000389	0.00121	CcSEcCtD
Estriol—Pain—Doxorubicin—sarcoma	0.000387	0.00121	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—sarcoma	0.000387	0.00121	CcSEcCtD
Estriol—ESR1—Gene Expression—FUS—sarcoma	0.000384	0.00211	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000382	0.0021	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000382	0.0021	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000371	0.00115	CcSEcCtD
Estriol—Hypersensitivity—Epirubicin—sarcoma	0.000361	0.00112	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000361	0.00198	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.00036	0.00198	CbGpPWpGaD
Estriol—Urticaria—Doxorubicin—sarcoma	0.00036	0.00112	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000358	0.00197	CbGpPWpGaD
Estriol—Abdominal pain—Doxorubicin—sarcoma	0.000358	0.00112	CcSEcCtD
Estriol—Pruritus—Epirubicin—sarcoma	0.000346	0.00108	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.000346	0.0019	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00034	0.00187	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—sarcoma	0.000335	0.00104	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—sarcoma	0.000334	0.00104	CcSEcCtD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000328	0.0018	CbGpPWpGaD
Estriol—Dizziness—Epirubicin—sarcoma	0.000324	0.00101	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000321	0.00177	CbGpPWpGaD
Estriol—Pruritus—Doxorubicin—sarcoma	0.000321	0.000998	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000314	0.00173	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000313	0.00172	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—sarcoma	0.000311	0.00097	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000311	0.00171	CbGpPWpGaD
Estriol—Diarrhoea—Doxorubicin—sarcoma	0.00031	0.000966	CcSEcCtD
Estriol—Rash—Epirubicin—sarcoma	0.000309	0.000962	CcSEcCtD
Estriol—Dermatitis—Epirubicin—sarcoma	0.000308	0.000961	CcSEcCtD
Estriol—Headache—Epirubicin—sarcoma	0.000307	0.000955	CcSEcCtD
Estriol—Dizziness—Doxorubicin—sarcoma	0.0003	0.000933	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000298	0.00164	CbGpPWpGaD
Estriol—Nausea—Epirubicin—sarcoma	0.000291	0.000906	CcSEcCtD
Estriol—Vomiting—Doxorubicin—sarcoma	0.000288	0.000897	CcSEcCtD
Estriol—ABCB1—Allograft Rejection—IL2—sarcoma	0.000286	0.00157	CbGpPWpGaD
Estriol—Rash—Doxorubicin—sarcoma	0.000286	0.00089	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—sarcoma	0.000285	0.000889	CcSEcCtD
Estriol—Headache—Doxorubicin—sarcoma	0.000284	0.000884	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000281	0.00154	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000274	0.00151	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—sarcoma	0.000269	0.000838	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000269	0.00148	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.00026	0.00143	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000259	0.00143	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000259	0.00142	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000257	0.00142	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000252	0.00138	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000246	0.00135	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000245	0.00135	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—VEGFA—sarcoma	0.000243	0.00134	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000233	0.00128	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000233	0.00128	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.000231	0.00127	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000227	0.00125	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000209	0.00115	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000207	0.00114	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—MYC—sarcoma	0.000205	0.00113	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000204	0.00112	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000197	0.00108	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000193	0.00106	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000191	0.00105	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ENO2—sarcoma	0.00019	0.00104	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—HBA1—sarcoma	0.000189	0.00104	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000171	0.000942	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TLE1—sarcoma	0.000164	0.000905	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PLCG1—sarcoma	0.000161	0.000886	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000158	0.000869	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VEGFC—sarcoma	0.000139	0.000763	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000138	0.000757	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000137	0.000755	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000136	0.00075	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000123	0.000677	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.00012	0.00066	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FLT1—sarcoma	0.000111	0.00061	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.00011	0.000607	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PLCG1—sarcoma	0.000109	0.0006	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000108	0.000594	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCR4—sarcoma	0.000105	0.000576	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MYC—sarcoma	0.000104	0.00057	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ATF1—sarcoma	0.000104	0.00057	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000102	0.000561	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MYC—sarcoma	9.89e-05	0.000544	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	9.06e-05	0.000499	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ENO2—sarcoma	8.13e-05	0.000447	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IGF1R—sarcoma	8.13e-05	0.000447	CbGpPWpGaD
Estriol—ABCB1—Metabolism—HBA1—sarcoma	8.08e-05	0.000444	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FOXO1—sarcoma	7.73e-05	0.000426	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PDGFRB—sarcoma	7.72e-05	0.000425	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PDGFRA—sarcoma	7.6e-05	0.000418	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PLCG1—sarcoma	6.9e-05	0.000379	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KDR—sarcoma	6.4e-05	0.000352	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KIT—sarcoma	5.89e-05	0.000324	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CREB1—sarcoma	5.61e-05	0.000309	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MYC—sarcoma	4.99e-05	0.000274	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MDM2—sarcoma	4.64e-05	0.000255	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL2—sarcoma	4.15e-05	0.000228	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCND1—sarcoma	4.04e-05	0.000222	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—JUN—sarcoma	4.03e-05	0.000222	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CTNNB1—sarcoma	4e-05	0.00022	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SRC—sarcoma	3.62e-05	0.000199	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—VEGFA—sarcoma	3.52e-05	0.000194	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NRAS—sarcoma	3.48e-05	0.000192	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MYC—sarcoma	3.24e-05	0.000178	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—sarcoma	3.17e-05	0.000175	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KRAS—sarcoma	3e-05	0.000165	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—sarcoma	2.66e-05	0.000147	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—sarcoma	2.55e-05	0.00014	CbGpPWpGaD
